BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22778783)

  • 1. The HYP-RT hypoxic tumour radiotherapy algorithm and accelerated repopulation dose per fraction study.
    Harriss-Phillips WM; Bezak E; Yeoh E
    Comput Math Methods Med; 2012; 2012():363564. PubMed ID: 22778783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.
    Harriss-Phillips WM; Bezak E; Yeoh EK
    Br J Radiol; 2011 Oct; 84(1006):903-18. PubMed ID: 21933980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered fractionation outcomes for hypoxic head and neck cancer using the HYP-RT Monte Carlo model.
    Harriss-Phillips WM; Bezak E; Yeoh EK
    Br J Radiol; 2013 Apr; 86(1024):20120443. PubMed ID: 23392195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Monte Carlo modelling of individual tumour cell propagation for hypoxic head and neck cancer.
    Tuckwell W; Bezak E; Yeoh E; Marcu L
    Phys Med Biol; 2008 Sep; 53(17):4489-507. PubMed ID: 18677039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas.
    Marcu L; van Doorn T; Olver I
    Phys Med Biol; 2004 Aug; 49(16):3767-79. PubMed ID: 15446804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of reoxygenation during fractionated radiotherapy in head and neck squamous cell carcinoma xenografts.
    Harriss W; Bezak E; Yeoh E; Hermans M
    Australas Phys Eng Sci Med; 2010 Sep; 33(3):251-63. PubMed ID: 20878297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive modeling of hypoxic head and neck cancers during fractionated radiotherapy with gold nanoparticle radiosensitization.
    Huynh M; Kempson I; Bezak E; Phillips W
    Med Phys; 2021 Jun; 48(6):3120-3133. PubMed ID: 33818799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.
    Jeong J; Shoghi KI; Deasy JO
    Phys Med Biol; 2013 Jul; 58(14):4897-919. PubMed ID: 23787766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
    Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
    Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy.
    Marcu LG; Marcu D; Filip SM
    Cell Prolif; 2016 Jun; 49(3):304-14. PubMed ID: 27079860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
    Lindblom E; Dasu A; Toma-Dasu I
    Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.
    Lindblom E; Antonovic L; Dasu A; Lax I; Wersäll P; Toma-Dasu I
    Radiat Oncol; 2014 Jun; 9():149. PubMed ID: 24974778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia.
    Ruggieri R
    Phys Med Biol; 2004 Oct; 49(20):4811-23. PubMed ID: 15566177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized Hypofractionation Can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer.
    Shuryak I; Hall EJ; Brenner DJ
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):272-278. PubMed ID: 30776451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling.
    Fowler JF
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):8-22. PubMed ID: 17305251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of tumour hypoxic fraction from clinical data sets compatible with accelerated repopulation.
    Jones B; Dale RG
    Acta Oncol; 1998; 37(3):263-8. PubMed ID: 9677098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stochastic Predictions of Cell Kill During Stereotactic Ablative Radiation Therapy: Do Hypoxia and Reoxygenation Really Matter?
    Harriss-Phillips WM; Bezak E; Potter A
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1290-7. PubMed ID: 27212197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy.
    McAneney H; O'Rourke SF
    Phys Med Biol; 2007 Feb; 52(4):1039-54. PubMed ID: 17264369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.
    Marcu L; Bezak E
    Phys Med; 2010 Oct; 26(4):177-83. PubMed ID: 20034829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.